Report from Sectra's Annual General Meeting

Report from Sectra's Annual General Meeting

The Annual General Meeting (AGM) of shareholders in Sectra AB (publ) was held
today in Linköping.

“For the first time in our history, we reported order bookings exceeding SEK 1
billion. We had major success in concluding service and support agreements with
customers that previously have been using our system for handling digital
radiology images, and we met our profit target of a profit margin of more than
10%,” said President and CEO Jan-Olof Brüer in his address to the Annual General
Meeting, which was attended by approximately 70 shareholders. 

Jan-Olof Brüer also mentioned in his address that the final part of the
application for approval to sell the Sectra MicroDose Mammography system in the
US was submitted to the FDA in June as planned. 

The Annual General Meeting adopted the income statement and balance sheet, as
well as the consolidated income statement and balance sheet, presented to the
Meeting. The members of the Board of Directors and the President were discharged
from liability for the fiscal year.

Dividend
The Meeting approved the distribution to shareholders of a dividend of SEK 0.50
per share, amounting to a total dividend of SEK 18,421,044.00. June 30 was
established as the record date for the dividend, which is to be paid through VPC
on July 3, 2008.

Election of the Board of Directors
Erika Johnson, Torbjörn Kronander, Anders Persson and Carl-Erik Ridderstråle
were re-elected to the Board. Christer Nilsson, Director Growth Capital at 3i,
was elected new Board member. Carl-Erik Ridderstråle was re-elected Chairman of
the Board. 

Nomination Committee
The Meeting decided to appoint a Nomination Committee comprising four members,
of whom one will be the Chairman of the Board and three will represent major
shareholders in the company. The members of the Nomination Committee will be
appointed effective October 31, 2008, after consultation with major shareholders
in the company. The Nomination Committee will prepare and present proposals to
the Annual General Meeting for the election of the chairman of the Meeting,
Chairman of the Board and other Board members, as well as proposals for the fees
to be paid to the Board members and resolution regarding principles for
composition of the Nomination Committee. Where applicable, the Nomination
Committee will also propose candidates for the election of auditors and fees to
be paid to the auditors. 

Authorizations
The Meeting authorized the Board to decide on the new issue of not more than
3,600,000 Series B shares, for consideration paid in cash, via an issue
offsetting debt or capital contributed in kind. Such a new issue may disregard
shareholders' preferential rights. If the authorization is fully utilized, the
dilution effect will be approximately 10% in terms of share capital and
approximately 6% in terms of voting rights. 

The Meeting also voted to authorize the Board to purchase or sell Series B
treasury shares on one or more occasions during the period ending at the next
Annual General Meeting. The authorization is restricted to actions that would
not cause the company's treasury share holdings to exceed 10% of all of the
shares in the company.

Convertible and stock option programs 
The Meeting voted in accordance with a motion to issue convertibles to Group
employees and to external Board members. The convertibles may be subscribed for
during the period September 29-October 10, 2008, and conversion to Series B
shares will be possible during May 23-27, 2011. Assuming full distribution, the
maximum dilution effect would be 1% of the share capital. 

The Meeting also adopted the Board's motion to distribute an additional maximum
of 100,000 employee stock options to Group employees in the US. If these
employee stock options are fully exercised, employees will acquire shares in the
company in a number corresponding to approximately 0.3% of the share capital and
0.2% of the voting rights. 

Principles for remuneration and other terms of employment for company management
The Meeting adopted the Board's motion that the principles for remuneration to
company management, which includes the President and other members of Group
management, adopted at the 2007 Annual General Meeting in all significant
respects shall continue to apply unchanged. Remuneration shall be formulated in
accordance with market conditions and simultaneously support the interests of
shareholders. Remuneration shall primarily comprise basic salary, variable
salary, defined-premium pension benefits and other benefits, for example, a
company car. 

Furthermore, the Meeting adopted the Board's motion that Board members with
special expertise, who perform services for the company in addition to Board
assignments, should receive market-based fees.


For further information, please contact: 
Dr. Jan-Olof Brüer, CEO and President Sectra AB, tel +46 13 23 52 09

About Sectra
Sectra successfully develops and sells cutting-edge products in the expansive
niche segments of medical systems and secure communication systems. The company
was founded in 1978 and has its roots in the Linköping University in Sweden.
Today, Sectra has offices in eleven countries and operates through partners
worldwide. Sales in the 2007/2008 fiscal year totaled SEK 743 million. The
Sectra share is quoted on the Nordic Exchange in Stockholm. For more
information about Sectra visit http://www.sectra.com.